The old proverb “Don’t judge a book by its cover” is meant to discourage people from drawing conclusions about someone based on their outward appearance. However, a new study suggests that there is a certain amount of information to be gained from observing a person’s exterior features. Specifically, it’s possible to determine if someone is rich or poor based on their facial expression.
The study was done by researchers at the Faculty of Arts and Science at the University of Toronto. Posting their findings in the Journal of Personality and Social Psychology, the results have significance to anyone who might be wondering why opportunities keep evading them. For one thing, being judged based on one’s facial expression can lead to rejection when applying for a job.
The researchers basically conducted an investigation using photos of two individuals and had “perceivers” judge these subjects’ socioeconomic standing. A neutral expression was necessary because it produced more telling results.
“Indeed, neutrally posed rich targets displayed more positive affect relative to poor targets and perceivers used this affective information to categorize their social class,” the paper reads. “Impressions of social class from these facial cues also influenced participants’ evaluations of the targets’ employability, demonstrating that face-based perceptions of social class may have important downstream consequences”
In its essence, the study proposes that by simply looking at a face with a “neutral” expression, it is possible to determine that person’s financial situation. As Thora Bjornsdottir, one of the researchers behind the study notes, even the smallest of details regarding the face can influence numerous aspects of life, Phys.org reports.
"It indicates that something as subtle as the signals in your face about your social class can actually then perpetuate it," Bjornsdottir said. "Those first impressions can become a sort of self-fulfilling prophesy. It's going to influence your interactions, and the opportunities you have."


Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
Tabletop particle accelerator could transform medicine and materials science
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 



